New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 19, 2014
08:50 EDTLH, LMNXLabCorp announces availability of xTAG CYP2D6 genotype assay
LabCorp (LH) announced the availability of the xTAG CYP2D6 Kit v3 from Luminex (LMNX). The xTAG CYP2D6 Kit v3 is an FDA cleared qualitative genotyping assay that aids clinicians in determining strategies for therapeutics metabolized by the CYP2D6 gene product.
News For LH;LMNX From The Last 14 Days
Check below for free stories on LH;LMNX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2014
14:41 EDTLMNX, LHFDA draft lab tests guidelines not as bad as feared, says Piper Jaffray
Subscribe for More Information
11:29 EDTLHFDA announces steps to ensure reliable diagnostic test results
Subscribe for More Information
July 29, 2014
08:15 EDTLMNXEnzo Biochem announces August 18 as date of Markman hearing in lawsuit
Subscribe for More Information
July 28, 2014
16:18 EDTLMNXLuminex backs FY14 revenue view $225M-$240M, consensus $231.08M
Subscribe for More Information
16:17 EDTLMNXLuminex reports Q2 adjusted EPS 20c, consensus 10c
Subscribe for More Information
07:26 EDTLMNXAmerican Association for Clinical Chemistry to hold annual meeting
Subscribe for More Information
July 21, 2014
08:09 EDTLHLabCorp price target raised to $130 from $120 at Maxim
Subscribe for More Information
July 18, 2014
12:04 EDTLHLabCorp pullback a buying opportunity, says Maxim
Subscribe for More Information
11:25 EDTLHPiper awaits notable volume recovery to get more positive on LabCorp
Piper Jaffray views LabCorp's in-line quarter as positive and said restored TRICARE coverage may provide added upside, but the firm would like to see notable lab volume recovery and a pullback in the shares before becoming more positive on the stock. Piper raised its price target on the stock to $99 from $98 and maintains its Neutral rating on LabCorp.
06:43 EDTLHLabCorp raises FY14 adjusted EPS to $6.50-$6.75 from $6.40-$6.70
Subscribe for More Information
06:43 EDTLHLabCorp: Q2 sales increase due to test volume
Total test volume increased 5.3%, while revenue per requisition decreased 2.0% due to test and payer mix. Reports Q2 operating income $246.7M, operating cash flow $207.4M, free cash flow $159M
06:41 EDTLHLabCorp reports Q2 adjusted EPS $1.84, consensus $1.77
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use